Please assess the completion status of the following clinical trial:

Trial Title: Prospective Comparison of Revolve™ and AuraGen 123 With AuraClens™ in Autologous Fat Grafting to the Breast

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female patients \> 18 years and \< 65 years of age~* Patients undergoing an aesthetic fat grafting procedure to the breast (breast augmentation) without a breast implant.~* Patients must be able to provide written informed consent, understand and be willing to comply with study-related procedures and follow-up visits.~* Patients must be non-smokers.~* Patients with available/adequate harvest sites for fat grafting.~* Anticipated harvested fat volume between 400 and 1400 cc~* Anticipated fat injection volume 150-350 cc per breast~* Patients must agree to maintain their weight (i.e. within 5%) by not making any major changes in their diet or lifestyle during the study.~Exclusion Criteria:~* Skin rash in the treatment area.~* Patients who smoke or use nicotine products.~* Patients with bleeding disorders or currently taking anticoagulants.~* Patients with a history of trauma or surgery to the treatment area.~* Patients with a history of breast cancer.~* Active, chronic, or recurrent infection.~* Compromised immune system (e.g. diabetes).~* Hypersensitivity to analgesic agents.~* Co-morbid conditions that could limit their ability to participate in the study or to comply with follow-up requirements.~* Untreated drug and/or alcohol abuse.~* Pregnant or breastfeeding.~* Any issue that, at the discretion of the investigator, would contraindicate the patient's participation.~* Patients who do not wish to have the study area (breast) photographed~NOTE Please note that there is no remuneration for participation in this study.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Fat grafting with the AuraGen 1-2-3 with AuraClens System (Type: ACTIVE_COMPARATOR): Patients undergoing an aesthetic fat grafting procedure to the breast without a breast implant. Lipoaspirate processed with the AuraGen 1-2-3 with AuraClens system.
- Fat grafting with the Revolve System (Type: ACTIVE_COMPARATOR): Patients undergoing an aesthetic fat grafting procedure to the breast without a breast implant. Lipoaspirate processed with the Revolve System.

Based on this trial design, predict the completion outcome and termination type (if applicable).